Pharmacology

Drug Development Drug Mechanisms Psychoactive Substances Psychedelics Drug Safety Cannabinoids Hormones Opioids Synthetic Drugs Psychedelic Substances

Study Links Liver Enzyme Genes to Compulsive Cocaine Use in Rats

Differences in liver cocaine metabolism may shape compulsive use, leading researchers to pursue enzyme validation and biomarker searches.

UK Regulator Approves Novo Nordisk’s Wegovy Pill

Stories older than 24h

Interpol Sweep Seizes 6.4 Million Fake and Unapproved Medicines Worldwide

Definium Therapeutics Jumps to 52-Week High After Trump Order on Psychedelic Treatments

Trump Signs Order to Fast-Track Psychedelic Treatments

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

South Africa Receives First Lenacapavir Doses for Twice‑Yearly HIV Prevention

New Super-Potent Opioid Tied to 41 Tennessee Deaths Spreads Across U.S. and Canada

EPO Signals Patent Grant for Silo Pharma’s PTSD Prevention Approach

CDC Issues National Alert on Veterinary Sedative Medetomidine in Fentanyl Supply

NIH Identifies DFNZ, a Nitazene Opioid That Eased Pain in Rats Without Breathing Risks

U.S. Kratom Poisoning Reports Hit Record in 2025, CDC Study Finds

CDC Report Finds Record U.S. Kratom Poison Calls in 2025

Artelo Secures Fully Funded Investigator-Led Glaucoma Trial With Belfast Health Trust

GLP‑1 Use Under Scrutiny After Study on Tolerability and Delhi OTC Sales

NCI Pursues Preclinical Test of Ivermectin’s Anti-Cancer Activity

New Study Finds UK Nitazene Deaths Likely Undercounted by Up to a Third

GLP-1 Weight-Loss Boom Triggers Safety Warnings and New Oversight

Randomized Trial Finds Solriamfetol Improves Alertness in Early-Morning Shift Workers

Utah Panel Advances Kratom Ban as Lawmakers Split on Regulation